Oct 1 (Reuters) - Regeneus Ltd RGS.AX :
* REGENEUS LTD - RECEIVED A NOTICE OF ACCEPTANCE FOR ITS AUSTRALIAN PATENT APPLICATION
* REGENEUS-APPLICATION FOR USE OF BIOMARKERS TO MONITOR DISEASE PROGRESSION IN PATIENTS UNDER MESENCHYMAL STEM CELL THERAPY FOR INFLAMMATORY CONDITIONS